483
LGM Pharma LLCFDA 483 - LGM Pharma LLC - April 08, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
LGM Pharma LLC, an Active Pharmaceutical Ingredient Distributor in Erlanger, KY, was cited for significant quality system deficiencies during an FDA inspection from March to April 2022. The firm failed to adequately investigate customer complaints and critical deviations, leading to potential distribution of compromised products. Additionally, the inspection revealed issues with recording quality activities and proper vendor qualification and oversight.
Open in Dashboard
ID · 91297ae6-fb36-4023-978e-58e9b301f0ea